Division of General Electric Co.
Latest From Instrumentarium Corp.
Finland’s contributions to medtech are often less recognized than those of its Nordic cousins, Sweden and Denmark. But the country has produced its fair share of industry firsts and while in vitro diagnostics is a particular stronghold of Finland, its medical device innovators are no laggards, according to Medtech Insight’s sister publication, Clinica.
Bristol-Myers’ and AstraZeneca’s deal to acquire Amylin Pharmaceuticals for $7 billion, announced June 29, reaffirms the partners’ commitment to the vast and growing type 2 diabetes market, even if the competition is intense and the companies’ five-year-old alliance got off to a rocky start.
- Medical Devices
- Therapeutic Areas
- Western Europe
- Parent & Subsidiaries
- General Electric Co.
- Senior Management
Olli Rikkala, Pres. & CEO
Matti Salmivuori, Dir., Fin.
- Contact Info
Phone: (358) 1039411
P.O. Box 100 Helsinki, 00031
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.